Tafluprost

Tafluprost
Systematic (IUPAC) name
	isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate
Clinical data
Trade names	Saflutan, Taflotan, Tapros, Zioptan
AHFS/Drugs.com	International Drug Names
Pregnancy	US: C Risk not ruled out; ;
Administration	Topical (eye drops)
Legal status
Legal status	US: ℞-only;
Identifiers
CASRN	209860-87-7
ATC code	S01EE05 (WHO)
PubChem	CID 6433101
ChemSpider	8044182
UNII	1O6WQ6T7G3
ChEBI	CHEBI:66899
ChEMBL	CHEMBL1963683
Chemical data
Formula	C25H34F2O5
Molar mass	452.531266 g/mol
	SMILES CC(C)OC(=O)CCC\C=C/CC(C(O)CC1O)C1\C=C\C(F)(F)COc2ccccc2 ;
	InChI InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1 ;

Tafluprost (trade names Taflotan, marketed by Santen Pharmaceutical and Zioptan, by Merck (U.S.)) is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.^[1]^[2]

Taflotan contains 15 µg/ml Tafluprost. Taflotan sine is a preservative-free, single-dose formulation containing 0.3 ml per dose.^[3]

References[edit]

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

4. Sethi HS, Dhawan M, Naik MP, Gupta VS. Prostaglandin analogs in glaucoma. Astrocyte 2015;2:126-32.